cas 83279-44-1|| where to buy 1H-Imidazol-1-amine hydrochloride

Nom du produit:1H-Imidazol-1-amine hydrochloride

IUPAC Name:1H-imidazol-1-amine hydrochloride

Unité d'emballage	Stock disponible	Prix($)
CM255218-100mg	in stock	ȌȌ
CM255218-250mg	in stock	ƻƙſ
CM255218-1g	in stock	Ǖƙȷ
CM255218-5g	in stock	ɐƱȦ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 83279-44-1 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:83279-44-1; Formule moléculaire:C3H6ClN3; Point de fusion:-; Code SMILES:NN1C=CN=C1.[H]Cl; Densité:

: Numéro de catalogue:CM255218; Poids moléculaire:119.55; Point d'ébullition:; N° Mdl:MFCD26390998; Stockage:Keep in inert atmosphere, store at room temperature.

: Imidazoles; Imidazole is an important five-membered nitrogen-containing heterocyclic compound. Among the numerous heterocyclic compounds, imidazole and its derivatives are regarded as a unique and multifaceted scaffold material due to their diverse applications in industrial, organic and pharmaceutical chemistry. Imidazoles interact in different ways with many therapeutic targets, enzymes and receptors in biological systems and thus exhibit a wide range of biological activities. In particular, several imidazoles can be used as clinical drugs to treat various types of cancer with high therapeutic efficacy. Furthermore, imidazoles are one of the most critical segments in the field of anti-covid-19 virus drug discovery due to their ability to interact with active targets in living systems.; Imidazole Manufacturer; As a professional imidazole manufacturer, we can guarantee product quality and delivery time.our company has been committed to supply personalized product solutions to customers,pls consult us.